Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structures of human plasma β–factor XIIa cocrystallized with potent inhibitors

Journal Article · · Blood Advances

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1499717
Journal Information:
Blood Advances, Vol. 2, Issue 5; ISSN 2473-9529
Country of Publication:
United States
Language:
ENGLISH

References (31)

Intrinsic Pathway of Coagulation and Arterial Thrombosis journal December 2007
Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates journal February 1984
Refinement of Macromolecular Structures by the Maximum-Likelihood Method journal May 1997
Overview of the CCP 4 suite and current developments journal March 2011
The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule. journal April 1976
Major Inhibitors of the Contact Phase Coagulation Factors journal January 1987
Conformational Lability in Serine Protease Active Sites: Structures of Hepatocyte Growth Factor Activator (HGFA) Alone and with the Inhibitory Domain from HGFA Inhibitor-1B journal March 2005
Features and development of Coot journal March 2010
Structural and Mutational Analyses of the Molecular Interactions between the Catalytic Domain of Factor XIa and the Kunitz Protease Inhibitor Domain of Protease Nexin 2 journal August 2005
Factor Xa and thrombin as targets for new oral anticoagulants journal January 2011
The refined crystal structure of bovine β-trypsin at 1·8 Å resolution journal November 1975
Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1 journal August 2015
Inhibition of activated haceman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor) journal June 1978
Structural Basis for Inhibition Promiscuity of Dual Specific Thrombin and Factor Xa Blood Coagulation Inhibitors journal January 2001
Expression, Crystallization, and Three-dimensional Structure of the Catalytic Domain of Human Plasma Kallikrein journal September 2005
A Familial Hemorrhagic Trait Associated with a Deficiency of a Clot-Promoting Fraction of Plasma 1 journal April 1955
The ternary complex of antithrombin–anhydrothrombin–heparin reveals the basis of inhibitor specificity journal August 2004
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences journal February 2005
Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations journal May 2009
Crystal Structures of the FXIa Catalytic Domain in Complex with Ecotin Mutants Reveal Substrate-like Interactions journal November 2004
NMRPipe: A multidimensional spectral processing system based on UNIX pipes journal November 1995
Serpin-resistant mutants of human tissue-type plasminogen activator journal June 1989
Novel roles for factor XII-driven plasma contact activation system journal January 2008
Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates journal December 1981
The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding journal January 1978
Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo journal December 2009
High Throughput Substrate Specificity Profiling of Serine and Cysteine Proteases Using Solution-phase Fluorogenic Peptide Microarrays journal February 2005
Phaser crystallographic software journal July 2007
Canonical Inhibitor-like Interactions Explain Reactivity of α 1 -Proteinase Inhibitor Pittsburgh and Antithrombin with Proteinases journal July 2003
Coagulation factor XII protease domain crystal structure journal March 2015
The refined 1.9-Å X-ray crystal structure of d-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships journal April 1992